
DNA’s Stress-Reliever Can Mark the Spot for Cancer Mutations
Scientists have identified Topoisomerase IIb (TOP2B) as a crucial enzyme that, while resolving DNA tangles, marks specific regions prone to cancer-causing mutations. By analysing thousands of cancer genomes, the study reveals that TOP2B binding sites often coincide with genetic damage in critical driver genes.
By Uusküla-Reimand, Lee, Oh, Klein, Adler, Akhtar Alvi, Langille, Pasini, Cheng, Serafimova, Abd-Rabbo, Hou, Tsai, Bhat, Schramek, Wilson, Reimand

